Literature DB >> 3908375

[Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct].

G Assmann, H J Lenzen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3908375

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

1.  Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.

Authors:  G Feussner; J Bommer; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-01-19

2.  Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.

Authors:  G Feussner; R Ziegler
Journal:  Clin Investig       Date:  1992-07

3.  Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.

Authors:  G Feussner; A Wagner; R Ziegler
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

4.  Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.

Authors:  G Feussner; A Wagner; B Kohl; R Ziegler
Journal:  Clin Investig       Date:  1993-05

5.  Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.

Authors:  G Feussner; R Ziegler
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.